Zelira Therapeutics Limited (ASX: ZLD)
Health Care · Pharmaceuticals · AU
AU$—
— today · — 1Y
Zelira Therapeutics Limited (ASX: ZLD) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.24M and employs 8 people.
trading between 0.31 and 1.15.
Tweenvest scores Zelira Therapeutics Limited across four factors: quality 16/100, value 60/100. Its strongest factor is value.
ZLD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.24M
- Revenue (TTM)
- $430.00
- P/E
- —
- EPS
- -0.32
- Dividend yield
- —
- Beta (5Y)
- 0.61
- 52-week high
- AU$1.15
- 52-week low
- AU$0.31
- Avg volume (3M)
- —
- Shares outstanding
- 11.90M
- Employees
- 8
- Next earnings
- —
About Zelira Therapeutics Limited
Zelira Therapeutics Limited (ZLD.AX) is an Australian biopharmaceutical firm dedicated to the research, development, and commercialization of cannabinoid-derived medicines for a variety of medical conditions. Its product portfolio includes HOPE™ brand formulations, which are available in Pennsylvania and Louisiana, as well as Zenivol™, a cannabinoid-based medication designed to treat chronic insomnia. In addition to its prescription offerings, the company provides several over-the-counter (OTC) products. These include SprinJene™ for oral hygiene and RAF FIVE™ for dermatological applications. Zelira also markets ITURA™, an advanced topical relief cream formulated to target multiple symptoms such as numbness, tingling, muscle cramps, insensitivity, and pain associated with Peripheral Artery Disease and diabetes. Zelira maintains key strategic partnerships with academic and medical institutions, including Curtin University, the Telethon Kids Institute, the University of Western Australia, St. Vincent's Hospital, and the Children's Hospital of Philadelphia. Originally incorporated in 2003 as Zelda Therapeutics Limited, the company rebranded to Zelira Therapeutics Limited in December 2019. Its corporate headquarters are located in Perth, Australia.
- ISIN
- AU000000ZLD1
- Founded
- 2003
- Listed since
- Jul 25, 2003
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| LIR Life Sciences Corp.CNSX: SKNY | $4.44M | CA$0.22 | -8.33% |
| cbdMD, Inc.NYSEAM: YCBD | $4.37M | $0.36 | -7.67% |
| Nuformix plcLSE: NFX | $4.32M | £0.00 | -4.00% |
| Futura Medical plcAIM: FUM | $4.32M | £0.00 | 0.00% |
| Cannabis Poland S.A.WSE: CBD | $4.14M | zł0.23 | +4.59% |
| Instituto Rosenbusch S.A.BASE: ROSE | $4.07M | AR$145.00 | +3.20% |
| CordovaCann Corp.OTCPK: LVRL.F | $3.84M | $0.04 | +75.00% |
| PharmaTher Holdings Ltd.CNSX: PHRM | $3.83M | CA$0.06 | +9.09% |
Figures last refreshed Oct 11, 2026.